April 26, 2012 ·
Leave a comment
April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:
Gastroenterology
Hepatology
Infectious Disease
Internal Medicine
For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, ... read more »
TAGS: 
basic and clinical research biopharmaecutical consulting firm diagnostics drug development gastroenterology geographic impact of key opinion leaders health care professionals Hepatitis C hepatology HIV infectious diseases internal medicine key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOL strategy Kristen Smithwick market access medical affairs medical device medical marketing medical meetings speakers patient health payer marketing physicians pipeline planning pricing and reimbursement professional network mapping public health scientific journal publishing Thought Leader Select thought leaders in medicine treatment guidelines
April 18, 2012 ·
Leave a comment
April 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a urology engagement with a top 20 global pharmaceutical company.
The pharmaceutical company, a global leader in drug development for urological conditions, approached Thought Leader Select for support with its existing portfolio of medicines, as well as new drugs in its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s existing portfolio as well as its emerging pipeline, Thought Leader Select will deploy its in-house research group for a two-part assessment of the key opinion leader community in urology.
For the first wave of the assessment, the Thought Leader Select research group will validate the skills and experience of the urology specialists that currently comprise the company’s KOL roster. In addition, Thought Leader Select will identify new physicians appropriate for the panel, bringing the total roster to 40 thought leaders across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as ... read more »
TAGS: basic and clinical research biopharmaceutical diagnostics drug development key opinion leaders KOL engagement KOL identification KOL panel KOL profiling KOL roster KOLs in urology Kristen Smithwick medical devices medical meetings pharmaceuticals scientific journal publishing Thought Leader Select thought leaders treatment guidelines urology
April 12, 2012 ·
Leave a comment
New press release out today from the offices of Thought Leader Select:
April 12, 2012 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based consulting firm supporting the healthcare industry, is pleased to announce the hiring of Jason Bell as its newest sales executive for the American market.
Bell comes to Thought Leader Select with a solid track record of experience within the biopharmaceutical industry, working as a field hospital representative in support of critical new drug launches in multiple therapeutic areas and disease states, for companies including Allergan, Capellon Pharmaceuticals, and Auriga Pharmaceuticals. In addition to his in-the-field experience and perspective on collaborating with key opinion leaders in medicine to promote effective new treatments, Bell also brings experience gleaned from his time at Clinsys Alterna, a contract research organization (CRO). In his business development role at Clinsys Alterna, Jason consulted with biopharmaceutical industry executives to deliver customized solutions in support of phase I-IV clinical trials.
Jason Bell is a 1997 graduate of California University of Pennsylvania, with a degree in psychology.
“I’m already enjoying my work, speaking with clients and prospective clients about their needs for medical marketing and medical science outreach to health care professionals,” stated Bell. “This company is a great match for my experience and the skills I developed in pharma, CROs, and talent management organizations serving life science ... read more »
TAGS: Allergan Auriga Pharmaceuticals biopharmaceutical industry Capellon Pharmaceuticals clinical trials Clinsys Alterna contract research organization CRO diagnostics drug launches healthcare industry Jason Bell medical devices Thought Leader Select
